Products
Our products
Learn more about our product portfolio and how we're prioritising vaccines and specialty medicines to get ahead of disease together.
Scroll to explore
Our product areas
Our portfolio spans three product areas: vaccines, specialty and general medicines. We’re prioritising R&D investment in vaccines and specialty medicines, which we expect to grow to around three quarters of our business by 2026.
Our medicines and vaccines
Getting ahead means preventing disease as well as treating it. Our R&D focus is to deliver new medicines and vaccines using the science of the immune system and advanced technologies to impact health at scale.33
Medicine and vaccine manufacturing sites in our global network
1.64bn
Packs of medicines delivered in 2025
389m
Vaccine doses delivered in 2025
100
Our general medicines reach people in more than 100 countries
